pentobarbital will minimize the extent or result of aripiprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lessen the level or impact of alosetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
Avoid coadministration of ganaxolone with average or solid CYP3A4 inducers. If coadministration unavoidable, consider increasing ganaxolone dose; nonetheless, tend not to exceed highest day by day dose for bodyweight.
pentobarbital will lessen the extent or impact of sildenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Powerful CYP3A4 inducers are envisioned to result in sizeable decreases in sildenafil plasma concentrations
pentobarbital will lower the extent or influence of levoketoconazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
Contraindicated (1)pentobarbital will decrease the level or effect of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
Soon after halting a CYP3A4 inducer, since the effects in the inducer drop, the fentanyl plasma focus will enhance which could maximize or lengthen both the therapeutic and adverse effects.
pentobarbital will lower the extent or outcome of dutasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.
pentobarbital will reduce the level or influence of zolpidem by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unfamiliar.
pentobarbital will lower the level or result more info of etoposide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will reduce the extent or result of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will minimize the extent or influence of rabeprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unknown.
pentobarbital will minimize the extent or impact of nilotinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will reduce the extent or outcome of zaleplon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.